Skip to main content
. 2017 May 23;14(1):885–890. doi: 10.3892/ol.2017.6231

Table II.

Tumor response.

EGFR mutation

Variables All patients (n=64) Mutant (n=15) Wild type (n=49) P-valuea
Complete response   2   0   2
Partial response 45 10 35
Stable disease 12   5   7
Progressive disease   4   0   4
Not evaluable   1   0   1
Response rate (%)   73.4   66.7   75.5 0.84
a

χ2 test; Mutant vs. Wild type; EGFR, epidermal growth factor receptor. Response rate = complete response + partial response.